Despite the expansion of total effector memory and effector CD8+ T cell subsets in CLL patients (Additional file 1: Fig. S2a, b), the frequency of those expressing CD26high was significantly lower in CLL patients (Fig. 1M, N). This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.